DangER: protein ovERload. Targeting protein degradation to treat myeloma.

Haematologica
L I Aronson, F E Davies

Abstract

Myeloma is a malignancy of the antibody-producing plasma cells and, as such, these cells synthesize large quantities of unfolded or misfolded immunoglobulin. The build-up of excess protein triggers a number of downstream signal transduction cascades, including endoplasmic reticulum stress and autophagy. As a result, myeloma cells are uniquely reliant on these and other protein handling pathways for their survival. Strategies aimed at targeting this vulnerability have proved successful with the proteasome inhibitor, bortezomib, already licensed for clinical use. In addition to the proteasome, various other points within the protein handling pathways are also the subject of drug discovery projects, with some already progressing into clinical trials. These include compounds directed against heat shock proteins, the unfolded protein response and pathways both upstream and downstream of the proteasome. More recently, the role of autophagy has been recognized in myeloma. In this review, we discuss the various pathways used by myeloma cells for survival, with particular emphasis on the emerging role and conundrum of autophagy, as well as highlighting pre-clinical research on novel inhibitors targeting protein handling pathways.

References

Oct 6, 1998·Nature·N MizushimaY Ohsumi
Dec 2, 2000·Nature·Y IchimuraY Ohsumi
Nov 26, 2002·Molecular and Cellular Biology·Monica G MarcuLen Neckers
Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Oct 16, 2003·Molecular and Cellular Biology·Ann-Hwee LeeLaurie H Glimcher
Nov 26, 2003·The Journal of Clinical Investigation·Xueping QuBeth Levine
Apr 8, 2004·Developmental Cell·Beth Levine, Daniel J Klionsky
Apr 13, 2004·Oncogene·Devrim Gozuacik, Adi Kimchi
Sep 2, 2004·Journal of the National Cancer Institute·Hae-Ryong ParkKazuo Shin-ya
Sep 2, 2004·Journal of Cell Science·Stefanie JägerEeva-Liisa Eskelinen
Sep 24, 2005·Cell·Sophie PattingreBeth Levine
Oct 20, 2005·Blood·Constantine S MitsiadesKenneth C Anderson
Oct 6, 2006·Molecular Biology of the Cell·Zhifen YangDaniel J Klionsky
Nov 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jens R SydorJeffrey K Tong
Nov 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lanie K FrancisIrene M Ghobrial
Jan 25, 2007·The EMBO Journal·Kassidy K HuynhSergio Grinstein
Feb 20, 2007·Cancer Research·Silke MeisterReinhard E Voll
Jun 26, 2007·Nature·Gian Maria FimiaFrancesco Cecconi
Jul 10, 2007·Cancer Research·Susan D DemoMark K Bennett
Jul 13, 2007·Cancer Chemotherapy and Pharmacology·Jon PattersonEmmanuel Normant
Nov 2, 2007·Nature Reviews. Cancer·Robin MathewEileen White
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alissa HustonIrene M Ghobrial
Feb 23, 2008·The Biochemical Journal·Laurence H PearlPaul Workman
Apr 17, 2008·Cell Cycle·Emma L DavenportFaith E Davies

❮ Previous
Next ❯

Citations

Aug 18, 2012·Nature Reviews. Cancer·Alan H ShihRoss L Levine
Apr 6, 2013·Immunotherapy·Alessandra RomanoFrancesco Di Raimondo
Oct 31, 2013·ELife·Arun P WiitaJames A Wells
Jan 21, 2014·Antioxidants & Redox Signaling·Guillem Paniagua SorianoBogdan I Florea
Aug 30, 2014·Expert Opinion on Biological Therapy·Claudia Andreu-Vieyra, James R Berenson
May 15, 2015·Bioconjugate Chemistry·Christopher G EnglandWeibo Cai
Apr 5, 2016·Oncogene·E MandatoF Piazza
Oct 10, 2014·British Journal of Haematology·Holger W Auner, Simone Cenci
Jun 30, 2015·Experimental Hematology·Naoya MimuraKenneth C Anderson
Apr 20, 2013·Cancer Cell·Richard G Carroll, Seamus J Martin
Mar 25, 2014·Frontiers in Immunology·Laura Oliva, Simone Cenci
May 13, 2017·Cell Death and Differentiation·Olivier Julien, James A Wells
Jul 21, 2017·Nature Reviews. Disease Primers·Shaji K KumarKenneth C Anderson
Dec 4, 2014·Therapeutic Advances in Hematology·Claudia V Andreu-Vieyra, James R Berenson
Aug 16, 2014·World Journal of Stem Cells·Antonio Garcia-GomezMercedes Garayoa
Feb 1, 2018·Oncotarget·Angela Isabel Pereira EugênioGisele Wally Braga Colleoni
Jun 22, 2016·Oncotarget·Jasmina S RedzicMichael W Graner
Jul 16, 2019·Oncotarget·Anna BanachRichard Z Lin
Mar 29, 2014·Oncotarget·Lei ZhangFaith E Davies
Mar 6, 2019·Current Molecular Medicine·Mariana B de OliveiraGisele W B Colleoni
Feb 3, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jacqueline H L FokFaith E Davies
Jan 6, 2021·Experimental Hematology & Oncology·Samah ElsaadiMagne Børset

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.